Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05934929 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Study acronym: MARGINS
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Feb 1, 2025 to Dec 22, 2025v2 Show 5 more changesShow less
    • Start date changed from estimate of Aug 1, 2023 to Jan 8, 2024
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 26 to confirmed 31
    • Study completion date: Aug 1, 2027 to Dec 29, 2027
    • Site contacts updated at 2 of 2 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the interest of residual tumour DNA research in the operating bed after squamous cell carcinoma excision.
Trial Details
NCT Number NCT05934929
Lead Sponsor Centre Henri Becquerel
Conditions
(from sponsor)		 Squamous Cell Carcinoma of the Oral Cavity
Related terms Carcinoma, Squamous Cell, Squamous Cell Carcinoma of Head and Neck
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov